Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 102, Issue 5, Pages 1486-1494
Publisher
The Endocrine Society
Online
2017-04-19
DOI
10.1210/jc.2016-3732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of follow-up of neuroendocrine neoplasias
- (2016) Ulrich-Frank Pape et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites
- (2016) Samira M. Sadowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors
- (2016) S. A. Deppen et al. JOURNAL OF NUCLEAR MEDICINE
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- (2016) M. Falconi et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
- (2016) B. Niederle et al. NEUROENDOCRINOLOGY
- Clinical value of 68Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET)
- (2015) D.R. Albanus et al. EUROPEAN JOURNAL OF RADIOLOGY
- Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma
- (2015) Jung Hoon Kim et al. EUROPEAN RADIOLOGY
- Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours
- (2015) S. Van Binnebeek et al. EUROPEAN RADIOLOGY
- Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas
- (2015) V. Ambrosini et al. JOURNAL OF NUCLEAR MEDICINE
- The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
- (2015) E. Skoura et al. JOURNAL OF NUCLEAR MEDICINE
- Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010
- (2015) Raziye Boyar Cetinkaya et al. NEUROENDOCRINOLOGY
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advanced Digestive Neuroendocrine Tumors
- (2014) Francesco Panzuto et al. PANCREAS
- Neuroendocrine Tumor Recurrence: Diagnosis with68Ga-DOTATATE PET/CT
- (2013) Alexander R. Haug et al. RADIOLOGY
- Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?
- (2012) Anna Sowa-Staszczak et al. CLINICAL IMAGING
- Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?
- (2012) Valentina Ambrosini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
- (2011) Nils F. Schreiter et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of 68Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours
- (2011) Rakesh Kumar et al. EUROPEAN RADIOLOGY
- Incremental Diagnostic Value and Impact on Patient Management of Somatostatin Receptor Scintigraphy with Indium-111-Pentetreotide in Gastroenteropancreatic Neuroendocrine Tumors
- (2011) Sharjeel Usmani et al. MEDICAL PRINCIPLES AND PRACTICE
- Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters
- (2010) Martin B Niederle et al. ENDOCRINE-RELATED CANCER
- Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
- (2010) Irene Virgolini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Follow-Up and Documentation
- (2009) Rudolf Arnold et al. NEUROENDOCRINOLOGY
- Impact of Multiphase68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
- (2009) Juri Ruf et al. NEUROENDOCRINOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started